首页|低分子肝素抗凝对慢性阻塞性肺疾病急性加重期患者肺通气、凝血功能和血NLR、PLR、NSE水平的影响

低分子肝素抗凝对慢性阻塞性肺疾病急性加重期患者肺通气、凝血功能和血NLR、PLR、NSE水平的影响

扫码查看
目的 探究低分子肝素(LMWH)抗凝对慢性阻塞性肺疾病急性加重期(AECOPD)患者肺通气、凝血功能及血中性粒细胞/淋巴细胞比值(NLR)、血小板淋巴细胞比值(PLR)、神经元特异性烯醇化酶(NSE)水平的影响.方法 选取2022 年6 月至2024 年3 月眉山市人民医院收治的65 例AECOPD患者为研究对象,按照随机数表法将患者分为LMWH组(33 例)与常规组(32 例).常规组患者接受吸氧、抗感染等常规对症治疗,LMWH组在常规组的基础上联合LMWH皮下注射.治疗1 周后,评估2 组患者临床疗效;治疗前后测定2 组患者肺通气、凝血功能、血NLR、PLR与NSE等指标.结果 LMWH组总有效率为 93.94%,显著高于常规组的 71.88%,差异有统计学意义(P<0.05).治疗后,2 组第1 秒用力呼气容积、用力肺活量、最大呼气峰流速、动脉血氧分压、氧饱和度显著高于治疗前,且LMWH组各项均高于常规组,差异均有统计学意义(P<0.05).治疗后,LMWH组动脉血二氧化碳分压(PaCO2)显著低于治疗前,且LMWH组PaCO2 低于常规组,差异有统计学意义(P<0.05).治疗后,2 组纤维蛋白原、D-二聚体、NLR与PLR、NSE水平显著低于治疗前,且LMWH组各项均低于常规组,差异有统计学意义(P<0.05).治疗后,LMWH组活化部分凝血活酶时间、凝血酶原时间较治疗前显著延长,且LMWH组均长于常规组,差异有统计学意义(P<0.05).2 组不良反应发生率比较,差异无统计学意义(P>0.05).结论 LMWH能明显改善AECOPD患者肺通气与凝血功能,降低血NLR、PLR与NSE水平,安全有效.
Effects of Low Molecular Weight Heparin Anticoagulation on Pulmonary Ventilation,Coagulation Function,Serum NLR,PLR and NSE Levels in Patients with AECOPD
Objective To investigate the effects of LMWH anticoagulation on pulmonary ventilation,coagulation function,serum neutrophil/lymphocyte ratio(NLR),platelet lymphocyte ratio(PLR)and neuron-specific enolase(NSE)levels in AECOPD patients.Methods 65 AECOPD patients admitted to Meishan people's hospital from June 2022 to March 2024 were included into LMWH group(n=33),subcutaneous injection of LMWH based on routine treatment)and routine group(n=32),routine symptomatic treatment,such as oxygen inhalation and anti-infection)by random number table meth-od.The curative effect was evaluated after 1 week of treatment.Pulmonary ventilation,coagulation function,serum NLR,PLR and NSE were measured before and after 1 week of treatment.Results The total effective rate was significantly higher in the LMWH group(93.94%)compared to the routine group(71.88%)After 1 week of treatment,forced expiratory volume,forced vital capacity,peak expiratory flow rate,arterial partial oxygen pressure and oxygen saturation in the two groups in-creased after treatment,and the LMWH group were higher(P<0.05),while the partial blood pressure of carbon dioxide(PaCO2)was significantly lower(P<0.05).After 1 week of treatment,the levels of fibrinogen,D-dimer,serum NLR,PLR and NSE in the two groups decreased after treatment,and the LMWH group was lower(P<0.05),while activated partial thromboplastin time and prothrombin time were significantly longer(P<0.05).There was no statistically significant difference in adverse reactions between the two groups(P>0.05).Conclusion LMWH can significantly improve pulmonary ventila-tion and coagulation function,and reduce serum NLR,PLR and NSE levels in AECOPD patients,which is safe and effective.

Acute exacerbation of chronic obstructive pulmonary diseaseLow molecular weight heparinPulmonary ventilationCoagulation functionNeutrophil/lymphocyte ratioPlatelet lymphocyte ratioNeuron-specific enolase

杨婵娟、王贝、吴苏、管弦、李俊、徐维彬

展开 >

620010 四川 眉山,眉山市人民医院呼吸与危重症医学科

慢性阻塞性肺疾病急性加重期 低分子肝素 肺通气 凝血功能 中性粒细胞/淋巴细胞比值 血小板淋巴细胞比值 神经元特异性烯醇化酶

2024

转化医学杂志
海军总医院

转化医学杂志

CSTPCD
影响因子:0.671
ISSN:2095-3097
年,卷(期):2024.13(7)